Panbela Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PBLA and buy or sell other stocks, ETFs, and their options commission-free!About PBLA
Panbela Therapeutics, Inc. engages in the development of disruptive therapeutics for medical purposes. It focuses on development programs that target diseases of the pancreas, including pancreatic cancer and pancreatitis.
CEOJennifer K. Simpson
CEOJennifer K. Simpson
Employees6
Employees6
HeadquartersWaconia, Minnesota
HeadquartersWaconia, Minnesota
Founded2011
Founded2011
Employees6
Employees6
PBLA Key Statistics
Market cap17.62M
Market cap17.62M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume15.79K
Average volume15.79K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$4.27
52 Week high$4.27
52 Week low$1.25
52 Week low$1.25
Stock Snapshot
As of today, Panbela Therapeutics(PBLA) shares are valued at $1.31. The company's market cap stands at 17.62M.
During the trading day, Panbela Therapeutics(PBLA) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Panbela Therapeutics(PBLA) stock has reached 0, versus its average volume of 15.79K.
Over the past 52 weeks, Panbela Therapeutics(PBLA) stock has traded between a high of $4.27 and a low of $1.25.
Over the past 52 weeks, Panbela Therapeutics(PBLA) stock has traded between a high of $4.27 and a low of $1.25.
People also own
Based on the portfolios of people who own PBLA. This list is generated using Robinhood data, and it’s not a recommendation.